Form 4 for IDXX Idexx Laboratories
Accepted 2024-03-04 00:00:00 ET · period of report 2024-02-29 · accession 0000874716-24-000061 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-04 | 2024-02-29 | IDXX | MAZELSKY JONATHAN JAY | Pres, CEO, Dir | G - Gift | $0.00 | -550 | 81.5K | -0.7% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-29 | G | D | 550 | $0.00 | 81,496.59 | D | — | — |